What is Cured?
Founded in 2018, Cured operates as a specialized healthcare technology firm dedicated to optimizing the connectivity between health systems, healthcare organizations, and their patient populations. The company provides a comprehensive suite of tools designed to streamline patient journeys, improve communication, and foster long-term loyalty within the healthcare ecosystem. By leveraging data-driven insights, Cured enables providers to deliver personalized care experiences, thereby addressing the critical need for digital transformation in an increasingly fragmented medical industry. Its market position is defined by its ability to integrate seamlessly with existing electronic health records and administrative workflows, making it an essential partner for modern health systems aiming to improve operational efficiency and patient outcomes.
How much funding has Cured raised?
Cured has raised a total of $67.5M across 2 funding rounds:
Angel/Seed
$2.5M
Series B
$65M
Angel/Seed (2019): $2.5M with participation from Matchstick Ventures, Waterline Ventures, and High Alpha
Series B (2021): $65M led by Inovia, Insight Partners, Bessemer Venture Partners, FundFire, and Ridge Ventures
Key Investors in Cured
Inovia
A full-stack venture firm that partners with founders to build enduring global technology companies, emphasizing a people-first investment philosophy.
Insight Partners
A global venture capital and private equity firm that supports software portfolio companies through a dedicated platform designed to foster leadership and operational scale.
Bessemer Venture Partners
A long-standing venture capital firm with a global footprint, known for its extensive history of backing transformative technology companies across various stages of development.
What's next for Cured?
Looking ahead, the capital injection will likely be deployed toward aggressive market expansion and the refinement of its core software-as-a-service offerings. As the healthcare sector continues to prioritize patient-centric digital experiences, Cured is strategically positioned to capitalize on the growing demand for interoperable health-tech solutions. The firm will likely focus on deepening its integration capabilities and expanding its reach into new regional markets, leveraging the expertise of its high-profile investor base to navigate regulatory complexities and scale its enterprise operations. Future growth will be contingent on the company's ability to maintain its product-market fit while scaling its revenue operations in a high-stakes, high-growth environment.
See full Cured company page
